Next Article in Journal
Staphylococcus aureus in Foodborne Diseases and Alternative Intervention Strategies to Overcome Antibiotic Resistance by Using Natural Antimicrobials
Previous Article in Journal
Soil Microbiome Drives Depth-Specific Priming Effects in Picea schrenkiana Forests Following Labile Carbon Input
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Emergence of Cryptosporidium parvum IIc Subtype and Giardia duodenalis Assemblage E in AIDS Patients in Central China: Evidence for Neglected Transmission Dynamics

1
National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
2
Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Chinese Academy of Sciences, Wuhan 430023, China
3
State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Microorganisms 2025, 13(8), 1731; https://doi.org/10.3390/microorganisms13081731
Submission received: 31 May 2025 / Revised: 14 July 2025 / Accepted: 17 July 2025 / Published: 24 July 2025

Abstract

Zoonotic opportunistic enteric protozoa represent a significant global health threat to immunocompromised populations, especially individuals with human immunodeficiency virus (HIV). Despite China’s severe HIV burden, molecular epidemiological data on enteric protozoa remain limited in this population. In this study, we investigated the occurrence and molecular characteristics of Cryptosporidium species, Giardia duodenalis, and Enterocytozoon bieneusi among 150 AIDS patients with severe immunodeficiency in Wuhan city, Hubei Province, China. The overall test-positive rate was 5.33% (8/150), comprising Cryptosporidium species (including C. hominis, C. parvum, and C. meleagridis) in 2.00% (3/150) and G. duodenalis (including assemblage A, B, and E) in 3.33% (5/150); E. bieneusi was not detected. Notably, this study reports the first identification of the C. parvum subtype IIcA5G3 in humans in China, certainly indicating possible cross-border transmission. Furthermore, the detection of C. meleagridis IIIbA22G1R1c provided additional molecular evidence for chicken-to-human transmission. The finding of G. duodenalis assemblage E highlights the underrecognized zoonotic spillover risks to immunocompromised populations. These findings emphasize the diversity of infectious reservoirs, and the need for enhanced national molecular surveillance of these neglected zoonotic enteric protozoa, alongside targeted interventions for vulnerable populations.

Graphical Abstract

1. Introduction

Acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV) has been one of the most devastating persisting pandemics of this era [1]. To date, there are 39.9 million people living with HIV (PLHIV) worldwide [2], and the progressive depletion of the cluster of differentiation 4 positive (CD4+ T) lymphocytes in PLHIV establishes an immunocompromised milieu conducive to opportunistic infections across bacterial, fungal, viral, and parasitic taxa, significantly elevating the risks of life-threatening complications [3,4,5,6,7,8].
Among parasitic protists, three zoonotic enteric protozoa demand heightened attention in immunocompromised populations: at least 19 species and 4 genotypes of Cryptosporidium, 6 assemblages (A–F) of Giardia duodenalis, and 106 genotypes of Enterocytozoon bieneusi have been reported in humans [9,10,11]. These pathogens exploit fecal–oral transmission routes via anthroponotic, zoonotic, or environmental pathways [12,13]. Infections exhibit a wide spectrum of clinical manifestations and vary among each pathogen. Common symptom clusters encompass diarrhea, malabsorption, wasting, etc., which could be moderate to severe, but are generally self-limiting or even asymptomatic in immunocompetent individuals [14]. Although antiretroviral therapy (ART) can restore immunity to these pathogens in HIV-1-infected individuals, eradicating the infection could still be a great challenge [15]. In addition, drug therapy for these enteric protozoa is far from optimal for PLHIV [16,17,18], which increases the risks of these infections to this population, exhibiting a considerable and increasing global burden, especially in developing countries with poverty [19].
Despite China’s severe HIV burden (1.329 million existing cases) [20], molecular epidemiological data on enteric protozoa in PLHIV remain strikingly limited. To date, only five epidemiological studies in China have characterized these pathogens at the molecular level among the PLHIV in Henan [21], Guangxi [22], Shanghai [23], Heilongjiang [24], and Jiangxi [25], respectively. Therefore, the actual situation remains far from fully elucidated, with critical knowledge gaps persisting concerning both regional heterogeneity in pathogen diversity and dominant species/genotypes and the respective contributions of anthroponotic vs. zoonotic transmission pathways.
Wuhan, as the largest city in Central China and one of the pivotal hubs in China’s railway, highway, shipping, and aviation networks, with large-scale population flow [26], exemplifies high-risk transmission interfaces between local and migrant populations, evidenced by its critical role in the early national dissemination of SARS-CoV-2 [27,28]. Previous studies in Hubei identified the enteric protozoa mentioned above in children, animals, and wastewater [29,30,31,32,33], while the associated data of PLHIV remain absent. Therefore, we investigate the incidence and molecular characteristics of Cryptosporidium spp., G. duodenalis, and E. bieneusi in AIDS patients, attempting to provide valuable information for a more in-depth understanding of the epidemiology and to seek evidence for potential sources of infection.

2. Materials and Methods

2.1. Collection of Specimens and Information

This study was conducted at Wuhan Jinyintan Hospital, in China, which is a designated medical institution for HIV/AIDS patients and virus carriers in Hubei Province, from September 2023 to April 2025. Eligible participants met the following inclusion criteria: (i) a confirmed HIV infection through nucleic acid amplification testing (NAAT) of viral RNA, and (ii) severe immunodeficiency defined as a CD4+ T-cell count < 200 cells/μL, measured within 48 h prior to enrollment.
Demographic and clinical data were systematically collected using a structured questionnaire. Key variables included age, sex, residential address (categorized as urban or rural), and most recent CD4+ T-cell count. Clinical manifestations of interest encompassed gastrointestinal symptoms (diarrhea, abdominal pain, vomiting, decreased appetite) and systemic features (fever, fatigue). Additional data on diagnosed co-infections (e.g., Peumocystis carinii peumonia, tuberculosis) were recorded when available.
Fresh stool specimens provided by the participants were immediately preserved by mixing with an equal volume of 2.5% (w/v) potassium dichromate solution and stored at 4 °C for subsequent molecular analysis.

2.2. Genomic DNA Extraction

FastDNATM SPIN Kit for Feces (MP Biomedical, Santa Ana, CA, USA) was employed to extract genomic DNA. A total of 0.5 mL of fecal materials was pipetted into a Matrix E tube, washed, and centrifuged twice with phosphate-buffered saline (PBS) solution; then, genomic DNA was extracted following the manufacturer-recommended procedures and stored at −20 °C until use.

2.3. Nested PCR

Nested PCR assays targeting the specific genes of each pathogen were conducted as follows: For Cryptosporidium spp., small subunit ribosomal RNA (SSU rRNA) was employed for species identification and classification [34], and the positive samples were further subtyped by sequence analyses of the 60-kDa glycoprotein gene (gp60) following established protocols [35,36]. For G. duodenalis, the triosephosphate isomerase (tpi), β-giardin (bg), and the glutamate dehydrogenase (gdh) genes were employed, and genetic assignment was to the level of assemblage [37,38]. For E. bieneuci, the internal transcribed spacer (ITS) of the nuclear ribosomal RNA gene was employed [39]. 2 × SanTaq PCR Mix (Sangong Biotech, Shanghai, China) was utilized for all reactions, and thermal cycling conditions followed the published protocols for each primer set (Table S1). Known test-positive genomic DNA (C. parvum IIdA19G1 from a calf, G. duodenalis assemblage E from cattle, G. duodenalis assemblage B from a rabbit, and E. bieneusi genotype 1 from cattle) and no-template controls (reagent-grade water) were included in each set of PCRs to ensure the absence of cross-contamination. Amplicons were visualized on 1.5% agarose gels stained with a Super Red nucleic acid stain (Biosharp life science, Hefei, China).

2.4. Indirect Immunofluorescence Microscopy Assay

Indirect immunofluorescence microscopy was performed on the positive specimens from the nested PCR for further verification. After preliminary purification to remove coarse debris, sediment of the 500 μL resuspended specimens was blocked with a 3% bovine serum albumin (BSA) in PBS (37 °C, 30 min) in 1.5 mL centrifuge tubes, then sequentially incubated with a primary antibody (1:500 dilution in 1% BSA/PBS; 4 °C, 12 h) and a fluorophore-conjugated secondary antibody (1:1000 dilution in PBS; 37 °C, 1 h). All incubations were followed by three PBS wash cycles (10,000× g, 5 min), and the samples were resuspended with 200 μL of PBS. Cryptosporidium oocysts were examined using a chicken yolk antibody against total C. parvum oocyst proteins paired with Alexa Fluor® 488-conjugated goat anti-chicken IgG (Abcam, Cambridge, UK). G. duodenalis cysts were examined using a mouse polyclonal antibody against prokaryotic recombinant β-giardin protein and CoraLite® 488-conjugated goat anti-mouse IgG (Proteintech, Wuhan, China). Three technical replicates per sample were examined by fluorescence microscopy under 488 nm excitation, with 10 μL of the final suspension mounted on glass slides.

2.5. Sequencing and Nucleotide Sequence Analysis

The PCR amplicons from the secondary PCR program of expected length were purified, and then bi-directionally sequenced on an ABI 3730Xl (Applied Biosystems, Foster City, CA, USA) by Tsingke Biotechnology (Beijing, China). The obtained nucleotide sequences were assembled using ChromasPro2.1.6 (http://technelysium.com.au/ChromasPro.html (accessed on 19 July 2025)), then aligned with each other and reference sequences which were downloaded from GenBank with their corresponding accession numbers (accession nos.) (https://www.ncbi.nlm.nih.gov (accessed on 19 July 2025)) using ClustalX 2.1 (www.clustal.org (accessed on 19 July 2025)).

2.6. Statistical Analysis

Given the low expected frequencies (<5 counts in >20% of cells) observed, categorical data analysis was performed using Fisher’s exact test (for 2 × 2 comparisons) or the Fisher-Freeman–Halton test (for r × c tables, r > 2 or c > 2) in SPSS software 26.0 (IBM Corp., Armonk, NY, USA). Statistical significance was defined as a two-tailed p-value < 0.05.

3. Results

3.1. Demographic Information

During the study period, fecal specimens were collected from 150 AIDS participants, among whom 140 were from 13 cities or areas in Hubei province, with 5 residing in 3 nearby provinces, while the remaining 5 did not provide complete information (Figure 1) (Table S2). The age of the subjects was between 19 and 80 years old (mean age  =  46.5 years old, median age = 48 years old), and the sex ratio (male–female) in the group was 135:11. The ratio of the residential areas of patients (urban–rural) was 57:89. Of the participants, 33.56% (49/146) were receiving ART, whereas 66.44% (97/146) were ART-naive or ART-experienced but discontinued (Table 1).

3.2. Occurrence of Cryptosporidium spp., Giardia duodenalis, and Enterocytozoon bieneusi

The overall test-positive rate of the three enteric protozoan infections was 5.33% (8/150). The test positive rate of Cryptosporidium spp. was 2.00% (3/150). Three Cryptosporidium species, including C. meleagridis (1 case), C. hominis (1 case), and C. parvum (1 case), were detected in three patients and successfully genotyped via a sequence analysis of the SSU rRNA gene (Table 1 and Table 2). Giardia duodenalis was detected in five patients, including assemblage A (1 case), assemblage B (3 cases), and assemblage E (1 case), and its test positive rate was 3.33% (5/150) (Table 1 and Table 3). None of the specimens tested positive for E. bieneusi, or for co-infection of Cryptosporidium spp. and G. duodenalis.
In the indirect immunofluorescence assay, the nested PCR-confirmed Cryptosporidium spp.-positive samples (n = 3) consistently exhibited intact oocysts with characteristic apple-green fluorescence under 488 nm excitation, whereas no cyst structures were visualized in any Giardia duodenalis-positive specimens, despite confirmed DNA detection by nested PCR (Figure 2). The microscopic examination exhibited inherently lower analytical sensitivity than the molecular assays, potentially accounting for suboptimal detection in the specimens with low fecal loads [40,41].

3.3. Characterization of Subtypes of Cryptosporidium spp. and Assemblages of Giardia duodenalis

According to the sequencing results of gp60 locus, the detected C. hominis, C. parvum, and C. meleagridis were further characterized as subtypes IfA12G1R5, IIcA5G3, and IIIbA22G1R1c, respectively (Table 2). Two of the five G. duodenalis-positive specimens were successfully amplified and genotyped at tpi, bg, and gdh loci (No. 1 and No. 2), and both were classified as assemblage B. The remaining three specimens were amplified and genotyped at only one locus, two at bg (No. 3 and No. 4) and one at tpi (No. 5) (Table 3).
All sequences obtained in this study demonstrated 100% nucleotide identity to the reference sequences deposited in GenBank, with host-geographical patterns across pathogen species or assemblages. The sequence of C. hominis showed 100% identity with reference sequences derived from several developed nations, while the sequence of C. parvum subtype IIc demonstrated exclusive phylogenetic clustering with clinical specimens collected from HIV-infected patients in Africa (Accession nos. AF440621, EU141721, and AF440631), which was consistent with the patient’s self-reported occupational exposure in Africa. Additionally, the sequence of gp60 from C. meleagridis showed genomic congruence with clinical isolates obtained from children with diarrhea in Hubei Province (Accession no. KY575457), with additional matches to poultry-derived strains in the same region (Accession no. MG969391) (Table 2).
For G. duodenalis assemblage B, the sequences of bg locus revealed divergent host specificity. Two sequences exclusively matched human-derived references (100% identity), while a third specimen (PV683348) additionally shared identity with a non-human primate (hylobatidae) isolate from China (KY696833). The sequences of tpi and gdh loci were exclusively conserved, and the sequences of gdh loci showed 100% identity to that derived from a non-human primate (hylobatidae) and a rabbit in China. For assemblage A, the tpi locus sequence matched with the sequences of a broad range of host species (Table S3). For assemblage E, the bg sequence differed from the positive controls and all prior isolates of our laboratory. However, it clustered with and exhibited 100% identity to a cattle-derived isolate (KY769091) from Chengdu, the patient’s residential area, thereby suggesting local livestock adaptation (Table 3). Collectively, these findings delineated distinct potential transmission patterns spanning anthroponotic spread (C. parvum IIc subtype), broad-spectrum zoonotic reservoirs (encompassing C. meleagridis and G. duodenalis including assemblages A and B), and potential livestock-adapted cycles (G. duodenalis assemblage E).

3.4. Statistical Analyses of Cryptosporidium spp. and Giardia duodenalis Infection Risks

The initial analysis using Fisher’s exact test demonstrated no significant associations between the infections of individual protozoan (Cryptosporidium spp. or G. duodenalis) and demographic stratification by age, gender, or residential area (p > 0.05). However, upon a group-wise amalgamation of the infection events, Fisher’s exact test revealed that elevated infection prevalence among rural populations showed statistically significant associations (p = 0.016) (Table 1).
Clinical profiling identified fatigue as the predominant symptom (29.45%, 43/146), succeeded by diarrhea (18.49%, 27/146), fever (17.12%, 25/146), vomiting (16.44%, 24/146), appetite loss (14.38%, 21/146), abdominal pain (6.16%, 9/146), and nausea (5.48%, 8/146). Only diarrhea exhibited statistically significant associations through Fisher’s exact tests, linking it to both Cryptosporidium infection (p = 0.005) and cumulative cases of Cryptosporidium and G. duodenalis infections (p = 0.046). All Cryptosporidium-positive cases clustered exclusively within the diarrheal subgroup (3/27 vs. 0/119-non-diarrheal cases), and the cumulative incidence of Cryptosporidium spp./G. duodenalis mono-infections was six-fold higher in diarrhea patients (14.81% vs. 2.52% in non-diarrheal cases) (Table 4). Detailed information on the test-positive patients is listed in Table S4.
As all samples were categorized by their collection seasons, Cryptosporidium spp. was detected only in specimens collected in the spring and winter, with positivity rates of 6.25% (2/32) and 1.89% (1/53), respectively. For G. duodenalis, the rates were 9.38% (3/32) in the spring vs. 3.77% (2/53) in the winter. None of the specimens collected in the summer (n = 36) or the autumn (n = 29) tested positive. Initial analyses using the Fisher–Freeman–Halton test (for 2 × 4 contingency tables) revealed no significant seasonal trends for either pathogen individually (Cryptosporidium spp.: p = 0.394; G. duodenalis: p = 0.221) or the pooled cases (p = 0.102) (Table 5).

4. Discussion

HIV/AIDS patients may function as “sentinel” populations for epidemiological surveillance in the context of immunocompromised host–pathogen interactions. Their distinct spectrum of opportunistic infections provides critical insights into identifying geographically restricted, emerging, or neglected pathogens [42]. Here, we identified C. hominis subtype IfA12G1R5, C. parvum subtype IIcA5G3, C. meleagridis subtype ⅢbA22G1R1, as well as G. duodenalis assemblages A, B, and E in AIDS patients, and formulated reliable hypotheses of different transmission routes or sources of infection.
In this study, we reported the first IIcA5G3 subtype of C. parvum, a subtype previously unreported in clinical surveillance in China, which is an almost exclusively anthroponotic subtype family, also designated C. parvum anthroponosum [9,43,44]. The IIc subtype causes the predominant C. parvum infection in low- and middle-income countries globally, especially in HIV-positive populations [45,46]. According to the patient’s self-reported occupational exposure in Africa, which is a recognized prevalent region for the IIc subtype, aligns with the hypothesis of cross-border transmission. Crucially, this case marks the first confirmed human infection with the IIc subtype within China, challenging its prior epidemiological absence. However, critical knowledge gaps persist regarding local transmission risks: the indeterminate infection timeline and incomplete activity tracing preclude a robust assessment of potential secondary transmission chains within the patient’s residential community. Worth mentioning is the import of C. parvum IIa subtypes into China, which is one of the main causes of human cryptosporidiosis in industrialized nations, and has occurred among grazing ruminants, posing insufficiently evaluated risks to both human and ruminant health domestically [47]. In light of this, the identification of the IIc subtype further underscores the necessity of enhanced molecular surveillance, which is critical to characterize transmission dynamics and evaluate clinical implications, particularly among immunocompromised and other vulnerable populations. The patient infected with C. meleagridis further enhances the current understanding of C. meleagridis transmission dynamics in Hubei province, with a confirmed 100% identity at the gp60 locus between the chicken-derived isolate [32], and the human-derived isolates including the AIDS patient and children [30]. The finding constitutes compelling phylogenetic evidence supporting zoonotic transmission, while the potential anthroponotic transmission mentioned previously cannot be discounted or excluded [46], particularly among children and immunodeficient populations.
Additionally, we also identified the IfA12G1R5 subtype of C. hominis, which is a relatively infrequent subtype in China. While this subtype has been recurrently reported in industrialized countries [48,49,50,51,52], one recent study has revealed that the predominant C. hominis hypertransmissable subtype IfA12G1R5 in the United States emerged from multiple introductions and recombination events, including IfA12G1R5 originating from Europe [53]. This finding underscores the importance of paying close attention to this particular subtype. The first documentation of IfA12G1 in China occurred only recently in Xinjiang and this subtype appears to maintain a sporadic pattern domestically [54]. The significant geographical separation between Xinjiang and Hubei (>2300 km apart) likely precludes direct human-to-human transmission chains between these regions. Nevertheless, potential transmission vectors involving transient population mobility or contaminated agricultural supply chains cannot be conclusively ruled out. However, it is a pity that the sequence data are not available for further comparing these two sequences. The If R repeat is complicated, and had been defined differently resulting in an alternative subtype nomenclature. It was not until 2025 that the R repeat designation was clarified [55]. Therefore, whether the sequence of IfA12G1 isolate contains R repeat sequence was unclear. Another plausible explanation might be that this subtype has exhibited sporadic transmission in at least two geographically distinct regions within China. One situation that requires greater concern might be that this subtype entered China through cross-border transmission, whereas the participant denied any overseas experience, and the absence of regional epidemiological data precludes further investigation for tracing. Whole genome sequencing (WGS) on the specimen in the future might validate our speculation. We should be more vigilant to avoid following in the footsteps of the United States, especially in the context of increasing population mobility, and call for integrating transnational health surveillance into national HIV programs. It is worth noting that at least two other studies documented different subtypes of the If family in China—among rhesus monkeys (Macaca mulatta) and in Shanghai’s wastewater systems [36,56]. Given the vast geographical heterogeneity of the C. hominis subtypes across China, current surveillance data remain critically insufficient. Complementary investigations targeting multisource objects (human, environmental, and zoonotic reservoirs) are imperative to elucidate the transmission networks of this protozoan.
For G. duodenalis, assemblage E is generally considered a hoofed livestock-specific genotype, while previous studies have broadened its host ranges in animals such as rabbits and non-human primates [57,58], and it has also been reported globally in over 50 human giardiasis cases in recent years [12]. In contrast, assemblage A has a broad range of mammalian hosts, especially subtype AI [59]. Notably, the detection of G. duodenalis assemblage E in the patient from Chengdu, Sichuan Province in our study, coupled with its 100% identity at bg locus to calf-derived sequences from Chengdu [60]. This finding suggests a potential zoonotic transmission of assemblage E in the region, mirroring the potential zoonotic patterns observed in other areas, such as Egypt and Australia [40,61]. In recent research, phylogenetic analysis supports the zoonotic transmission of G. intestinalis assemblage E from bovine to human hosts in agricultural settings in Egypt [62]. In addition, it is considered that assemblage E also presents both zoonotic and anthroponotic profiles [63]. These findings underscore the importance of enhancing surveillance systems for zoonotic protozoan parasites among both human and animal populations in rural and underdeveloped regions, in order to implement targeted intervention strategies for mitigating transmission risks. However, the limited clinical and epidemiological metadata in this study preclude definitive conclusions regarding transmission dynamics. Therefore, in the “One Health” framework, targeted investigations incorporating molecular surveillance of both human and livestock populations in this region, and genotyping based on other gene loci or WGS are warranted to validate these hypotheses.
Despite robust evidence for local transmission patterns, certain limitations should be noted. This study was conducted at a relatively low scale (only 150 patients enrolled), so the test-positivity could not convictively represent the overall prevalence in this population in Central China. Despite prior reported cases of E. bieneusi in Wuhan [30], none of the cases tested positive among AIDS patients, which seems to contrast with their heightened susceptibility to opportunistic pathogens. Here are three plausible explanations: First, the limited scale might preclude the finding of infected cases (95% CI: 0–2.5%). Second, while low pathogen loads may evade identification. Nested PCR remains the dominant technique for molecular epidemiology due to its direct genotyping capability via amplicon sequencing. Novel methods with superior sensitivity show future potential for human diagnostics [64,65]. Third, regional epidemiological variation might be neglected, which necessitates integrated surveillance across human, animal, and environmental reservoirs. Furthermore, due to the lack of precise temporal data on infection onset (a common limitation in cross-sectional studies compared to cohort designs), this study could not reliably assess the association between enteric protozoan infections and seasonal variations, which might also be a limitation in previous studies [66]. These limitations highlight the need for future work on (i) larger-scale population enrollment to enhance statistical power, (ii) systematic clinical and exposure-related metadata collection covering demographics, behavioral patterns, and histories of direct or environmental animal contact, and (iii) comparative genome-level analysis of isolates derived from different hosts to gather more comprehensive, directly linked, and more compelling evidence associated with these transmission dynamics.

5. Conclusions

This study uncovers the transmission risks of Cryptosporidium spp. and G. duodenalis among AIDS patients in Central China, holding direct implications for poverty-linked zoonotic infectious disease control. The first reported detection of C. parvum subtype IIcA5G3 phylogenetically linked to HIV-infected populations in Africa underscores cross-border pathogen dispersion through mobile populations, emphasizing the need to integrate transnational health surveillance into national HIV programs. Concurrently, the identification of C. meleagridis (ⅢbA22G1R1c), and G. duodenalis assemblages A and E in AIDS patients highlights zoonotic transmission, the vulnerabilities of rural areas, and the urban–rural interface. These findings might position AIDS patients as “sentinel” populations for monitoring zoonotic opportunistic pathogens and other “One Health” threats, urging us to pre-emptively address neglected or emerging protozoan prevalence.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/microorganisms13081731/s1: Table S1: Sequences of primers and thermal cycling programs utilized in each nested PCR; Table S2: Information on the geographical distribution of AIDS participants; Table S3: Accession nos. and geographical origins of target gene sequences from GenBank used for sequence analyses; Table S4: Detailed information on test-positive participants.

Author Contributions

Z.T.: Investigation, Methodology, Writing—original draft; K.H.: Investigation, Resources, Writing—review and editing; P.Q., H.L. and C.W.: Investigation, Writing—review and editing; J.Y., G.Z. and X.L.: Writing—review and editing; M.H.: Funding acquisition, Project administration, Resources, Supervision, Writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by grants from the National Key Research and Development Program of China (2022YFE0114500).

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Wuhan Jinyintan Hospital (KY-2023-31.01) on 16 October 2023.

Informed Consent Statement

Informed consent was obtained from all the subjects involved in this study. Prior to specimen collection, written informed consent was obtained from all participants after a comprehensive explanation of the study objectives, procedures, and data confidentiality measures.

Data Availability Statement

Nucleotide sequence data reported in this article were submitted and publicly available in the GenBank database (https://www.ncbi.nlm.nih.gov/ (accessed on 19 July 2025)) under accession nos. PV664587-PV664589, PV672203-PV672205, PV672206-PV672209, PV683347-PV683349, PV683351, and PV700082.

Acknowledgments

We would like to thank Li Liu and Li Chen of Wuhan Jinyintan Hospital for their assistance in data and sample collection. The graphical abstract was created with BioGDP (https://biogdp.com (accessed on 19 July 2025)) [67].

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
AIDSAcquired immunodeficiency syndrome
Accession no.Accession number
bgβ-gardin
BSABovine serum albumin
CD4+Cluster of differentiation 4 positive
gp6060-kDa glycoprotein gene
gdhGlutamate dehydrogenase
HIVHuman immunodeficiency virus
ITSInternal transcribed spacer
PBSPhosphate buffered saline
PCRPolymerase chain reaction
PLHIVPeople living with human immunodeficiency virus
SSU rRNASmall subunit ribosomal RNA
tpiTriosephosphate isomerase

References

  1. Beyrer, C.; Das, P.; Horton, R.; Ryan, O.; Bekker, L.G. The international AIDS society-Lancet commission on the future of the HIV response and global health. Lancet 2017, 390, 344–345. [Google Scholar] [CrossRef] [PubMed]
  2. AIDSinfo | UNAIDS. Available online: https://aidsinfo.unaids.org/ (accessed on 30 May 2025).
  3. El-Atrouni, W.; Berbari, E.; Temesgen, Z. HIV-associated opportunistic infections. J. Med. Liban. 2006, 54, 80–83. [Google Scholar] [PubMed]
  4. Limper, A.H.; Adenis, A.; Le, T.; Harrison, T.S. Fungal infections in HIV/AIDS. Lancet Infect. Dis. 2017, 17, e334–e343. [Google Scholar] [CrossRef] [PubMed]
  5. Lichtner, M.; Cicconi, P.; Vita, S.; Cozzi-Lepri, A.; Galli, M.; Caputo, S.L.; Saracino, A.; De Luca, A.; Moioli, M.; Maggiolo, F.; et al. Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J. Infect. Dis. 2015, 211, 178–186. [Google Scholar] [CrossRef] [PubMed]
  6. Martinez, J.; Temesgen, Z. Opportunistic infections in patients with HIV and AIDS. Fungal and parasitic infections. J. Med. Liban. 2006, 54, 84–90. [Google Scholar] [PubMed]
  7. Bekker, L.G.; Beyrer, C.; Mgodi, N.; Lewin, S.R.; Delany-Moretlwe, S.; Taiwo, B.; Masters, M.C.; Lazarus, J.V. HIV infection. Nat. Rev. Dis. Prim. 2023, 9, 42. [Google Scholar] [CrossRef] [PubMed]
  8. Adam, R.D. Giardia duodenalis: Biology and pathogenesis. Clin. Microbiol. Rev. 2021, 34, e00024-19. [Google Scholar] [CrossRef] [PubMed]
  9. Ryan, U.; Zahedi, A.; Feng, Y.; Xiao, L. An update on zoonotic Cryptosporidium species and genotypes in humans. Animals 2021, 11, 3307. [Google Scholar] [CrossRef] [PubMed]
  10. Shen, Y.; Gong, B.; Liu, X.; Wu, Y.; Yang, F.; Xu, J.; Zhang, X.; Cao, J.; Liu, A. First identification and genotyping of Enterocytozoon bieneusi in humans in Myanmar. BMC Microbiol. 2020, 20, 10. [Google Scholar] [CrossRef] [PubMed]
  11. Ruan, Y.; Xu, X.; He, Q.; Li, L.; Guo, J.; Bao, J.; Pan, G.; Li, T.; Zhou, Z. The largest meta-analysis on the global prevalence of Microsporidia in mammals, avian and water provides insights into the epidemic features of these ubiquitous pathogens. Parasit. Vectors 2021, 14, 186. [Google Scholar] [CrossRef] [PubMed]
  12. Ryan, U.M.; Feng, Y.; Fayer, R.; Xiao, L. Taxonomy and molecular epidemiology of Cryptosporidium and Giardia–a 50 year perspective (1971–2021). Int. J. Parasitol. 2021, 51, 1099–1119. [Google Scholar] [CrossRef] [PubMed]
  13. Li, W.; Feng, Y.; Xiao, L. Enterocytozoon bieneusi. Trends Parasitol. 2022, 38, 95–96. [Google Scholar] [CrossRef] [PubMed]
  14. Stark, D.; Barratt, J.L.N.; van Hal, S.; Marriott, D.; Harkness, J.; Ellis, J.T. Clinical significance of enteric protozoa in the immunosuppressed human population. Clin. Microbiol. Rev. 2009, 22, 634–650. [Google Scholar] [CrossRef] [PubMed]
  15. Carr, A.; Marriott, D.; Field, A.; Vasak, E.; Cooper, D.A. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998, 351, 256–261. [Google Scholar] [CrossRef] [PubMed]
  16. Amadi, B.; Mwiya, M.; Sianongo, S.; Payne, L.; Watuka, A.; Katubulushi, M.; Kelly, P. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: A randomised controlled trial. BMC Infect. Dis. 2009, 9, 195. [Google Scholar] [CrossRef] [PubMed]
  17. Nourrisson, C.; Lavergne, R.A.; Moniot, M.; Morio, F.; Poirier, P. Enterocytozoon bieneusi, a human pathogen. Emerg. Microbes Infect. 2024, 13, 2406276. [Google Scholar] [CrossRef] [PubMed]
  18. Bourque, D.L.; Neumayr, A.; Libman, M.; Chen, L.H. Treatment strategies for nitroimidazole-refractory giardiasis: A systematic review. J. Travel Med. 2022, 29, taab120. [Google Scholar] [CrossRef] [PubMed]
  19. Savioli, L.; Smith, H.; Thompson, A. Giardia and Cryptosporidium join the ‘neglected diseases initiative’. Trends Parasitol. 2006, 22, 203–208. [Google Scholar] [CrossRef] [PubMed]
  20. Chen, Z.; Xu, J.; Jin, X.; Wang, J.; Huang, J.; Zhang, H.; Chen, L.; Deng, K.; Cai, W.; Li, L.; et al. Grand challenges on HIV/AIDS in China—The 5th symposium, Yunnan 2024. Emerg. Microbes Infect. 2025, 14, 2492208. [Google Scholar] [CrossRef] [PubMed]
  21. Wang, L.; Zhang, H.; Zhao, X.; Zhang, L.; Zhang, G.; Guo, M.; Liu, L.; Feng, Y.; Xiao, L. Zoonotic Cryptosporidium species and Enterocytozoon bieneusi genotypes in HIV-positive patients on antiretroviral therapy. J. Clin. Microbiol. 2013, 51, 557–563. [Google Scholar] [CrossRef] [PubMed]
  22. Liu, H.; Xu, N.; Shen, Y.; Hu, Y.; Cao, J. Infection and genotype of Giardia lamblia among HIV/AIDS patients in Guangxi. Chin. J. Parasitol. Parasit. Dis. 2019, 37, 321–325. (In Chinese) [Google Scholar] [CrossRef]
  23. Jiang, Y.; Liu, L.; Yuan, Z.; Liu, A.; Cao, J.; Shen, Y. Molecular identification and genetic characteristics of Cryptosporidium spp., Giardia duodenalis, and Enterocytozoon bieneusi in human immunodeficiency virus/acquired immunodeficiency syndrome patients in Shanghai, China. Parasit. Vectors 2023, 16, 53. [Google Scholar] [CrossRef] [PubMed]
  24. Zhao, W.; Yao, L.; Zhuang, M.; Lin, Y.L.; Chen, X.H.; Wang, L.; Song, B.; Zhao, Y.-S.; Xiao, Y.; Zhang, F.M.; et al. A baseline epidemiological study of the co-infection of enteric protozoans with human immunodeficiency virus among men who have sex with men from Northeast China. PLoS Negl. Trop. Dis. 2022, 16, e0010712. [Google Scholar] [CrossRef] [PubMed]
  25. Hu, Z.; Lu, L.; Yu, Y.; Li, L.; Wang, W.; Fan, G.; Feng, C.; Deng, Y.; Peng, G. Prevalence and genetic characteristics of Cryptosporidium infections among HIV-positive individuals in Jiangxi Province. Chin. J. Schistosomiasis Control 2024, 36, 637–642. (In Chinese) [Google Scholar] [CrossRef]
  26. Zhang, C.; Wang, L. Research on the correlation of transportation and economic development in Wuhan. Appl. Mech. Mater. 2014, 505–506, 745–749. [Google Scholar] [CrossRef]
  27. Jia, J.S.; Lu, X.; Yuan, Y.; Xu, G.; Jia, J.; Christakis, N.A. Population flow drives spatio-temporal distribution of COVID-19 in China. Nature 2020, 582, 389–394. [Google Scholar] [CrossRef] [PubMed]
  28. Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.M.; Lau, E.H.Y.; Wong, J.Y.; et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N. Engl. J. Med. 2020, 382, 1199–1207. [Google Scholar] [CrossRef] [PubMed]
  29. Li, N.; Xiao, L.; Wang, L.; Zhao, S.; Zhao, X.; Duan, L.; Guo, M.; Liu, L.; Feng, Y. Molecular surveillance of Cryptosporidium spp., Giardia duodenalis, and Enterocytozoon bieneusi by genotyping and subtyping parasites in wastewater. PLoS Negl. Trop. Dis. 2012, 6, e1809. [Google Scholar] [CrossRef] [PubMed]
  30. Wang, T.; Fan, Y.; Koehler, A.V.; Ma, G.; Li, T.; Hu, M.; Gasser, R.B. First survey of Cryptosporidium, Giardia and Enterocytozoon in diarrhoeic children from Wuhan, China. Infect. Genet. Evol. 2017, 51, 127–131. [Google Scholar] [CrossRef] [PubMed]
  31. Fan, Y.; Wang, T.; Koehler, A.V.; Hu, M.; Gasser, R.B. Molecular investigation of Cryptosporidium and Giardia in pre- and post-weaned calves in Hubei Province, China. Parasit. Vectors 2017, 10, 519. [Google Scholar] [CrossRef] [PubMed]
  32. Liao, C.; Wang, T.; Koehler, A.V.; Fan, Y.; Hu, M.; Gasser, R.B. Molecular investigation of Cryptosporidium in farmed chickens in Hubei Province, China, identifies ‘zoonotic’ subtypes of C. meleagridis Parasit. Vectors 2018, 11, 484. [Google Scholar] [CrossRef] [PubMed]
  33. Li, D.; Deng, H.; Zheng, Y.; Zhang, H.; Wang, S.; He, L.; Zhao, J. First characterization and zoonotic potential of Cryptosporidium spp. and Giardia duodenalis in pigs in Hubei Province of China. Front. Cell. Infect. Microbiol. 2022, 12, 949773. [Google Scholar] [CrossRef] [PubMed]
  34. Xiao, L.; Morgan, U.M.; Limor, J.; Escalante, A.; Arrowood, M.; Shulaw, W.; Thompson, R.C.A.; Fayer, R.; Lal, A.A. Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Appl. Environ. Microbiol. 1999, 65, 3386–3391. [Google Scholar] [CrossRef] [PubMed]
  35. Stensvold, C.R.; Beser, J.; Axén, C.; Lebbad, M. High applicability of a novel method for gp60-based subtyping of Cryptosporidium meleagridis. J. Clin. Microbiol. 2014, 52, 2311–2319. [Google Scholar] [CrossRef] [PubMed]
  36. Feng, Y.; Li, N.; Duan, L.; Xiao, L. Cryptosporidium genotype and subtype distribution in raw wastewater in Shanghai, China: Evidence for possible unique Cryptosporidium hominis transmission. J. Clin. Microbiol. 2009, 47, 153–157. [Google Scholar] [CrossRef] [PubMed]
  37. Sulaiman, I.M.; Fayer, R.; Bern, C.; Gilman, R.H.; Trout, J.M.; Schantz, P.M.; Das, P.; Lal, A.A.; Xiao, L. Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg. Infect. Dis. 2003, 9, 1444–1452. [Google Scholar] [CrossRef] [PubMed]
  38. Cacciò, S.M.; de Giacomo, M.; Pozio, E. Sequence Analysis of the beta-giardin gene and development of a polymerase chain reaction-restriction fragment length polymorphism assay to genotype Giardia duodenalis cysts from human faecal samples. Int. J. Parasitol. 2002, 32, 1023–1030. [Google Scholar] [CrossRef] [PubMed]
  39. Sulaiman, I.M.; Fayer, R.; Lal, A.A.; Trout, J.M.; Schaefer, F.W.; Xiao, L. Molecular characterization of Microsporidia indicates that wild mammals harbor host-adapted Enterocytozoon spp. as well as human-pathogenic Enterocytozoon bieneusi. Appl. Environ. Microbiol. 2003, 69, 4495–4501. [Google Scholar] [CrossRef] [PubMed]
  40. Foronda, P.; Bargues, M.D.; Abreu-Acosta, N.; Periago, M.V.; Valero, M.A.; Valladares, B.; Mas-Coma, S. Identification of genotypes of Giardia intestinalis of human isolates in Egypt. Parasitol. Res. 2008, 103, 1177–1181. [Google Scholar] [CrossRef] [PubMed]
  41. Brožová, K.; Jirků, M.; Lhotská, Z.; Květoňová, D.; Kadlecová, O.; Stensvold, C.R.; Samaš, P.; Petrželková, K.J.; Jirků, K. The opportunistic protist, Giardia intestinalis, occurs in gut-healthy humans in a high-income country. Emerg. Microbes Infect. 2023, 12, 2270077. [Google Scholar] [CrossRef] [PubMed]
  42. Wang, C.; Shi, Y.; Liu, Y.; Zhou, Y.; Du, J.; Hu, X.; Li, W.; Li, J.; Gao, Y.; Li, G. Coinfection of hepatitis B, tuberculosis, and HIV/AIDS in Beijing from 2016 to 2023: A surveillance data analysis. BMC Infect. Dis. 2025, 25, 584. [Google Scholar] [CrossRef] [PubMed]
  43. Feng, Y.; Ryan, U.M.; Xiao, L. Genetic diversity and population structure of Cryptosporidium. Trends Parasitol. 2018, 34, 997–1011. [Google Scholar] [CrossRef] [PubMed]
  44. Nader, J.L.; Mathers, T.C.; Ward, B.J.; Pachebat, J.A.; Swain, M.T.; Robinson, G.; Chalmers, R.M.; Hunter, P.R.; Van Oosterhout, C.; Tyler, K.M. Evolutionary genomics of anthroponosis in Cryptosporidium. Nat. Microbiol. 2019, 4, 826–836. [Google Scholar] [CrossRef] [PubMed]
  45. King, P.; Tyler, K.M.; Hunter, P.R. Anthroponotic transmission of Cryptosporidium parvum predominates in countries with poorer sanitation: A systematic review and meta-analysis. Parasit. Vectors 2019, 12, 16. [Google Scholar] [CrossRef] [PubMed]
  46. Yang, X.; Guo, Y.; Xiao, L.; Feng, Y. Molecular Epidemiology of human cryptosporidiosis in low-and middle-income countries. Clin. Microbiol. Rev. 2021, 34, e00087-19. [Google Scholar] [CrossRef] [PubMed]
  47. Guo, Y.; Ryan, U.; Feng, Y.; Xiao, L. Emergence of zoonotic Cryptosporidium parvum in China. Trends Parasitol. 2022, 38, 335–343. [Google Scholar] [CrossRef] [PubMed]
  48. O’Brien, E.; McInnes, L.; Ryan, U. Cryptosporidium GP60 genotypes from humans and domesticated animals in Australia, North America and Europe. Exp. Parasitol. 2008, 118, 118–121. [Google Scholar] [CrossRef] [PubMed]
  49. Waldron, L.S.; Ferrari, B.C.; Power, M.L. Glycoprotein 60 diversity in C. hominis and C. parvum causing human cryptosporidiosis in NSW, Australia. Exp. Parasitol. 2009, 122, 124–127. [Google Scholar] [CrossRef] [PubMed]
  50. Ng, J.S.Y.; Pingault, N.; Gibbs, R.; Koehler, A.; Ryan, U. Molecular characterisation of Cryptosporidium outbreaks in western and south Australia. Exp. Parasitol. 2010, 125, 325–328. [Google Scholar] [CrossRef] [PubMed]
  51. Chalmers, R.M.; Hadfield, S.J.; Jackson, C.J.; Elwin, K.; Xiao, L.; Hunter, P. Geographic linkage and variation in Cryptosporidium hominis. Emerg. Infect. Dis. 2008, 14, 496–498. [Google Scholar] [CrossRef] [PubMed]
  52. Fill, M.M.A.; Lloyd, J.; Chakraverty, T.; Sweat, D.; Manners, J.; Garman, K.; Hlavsa, M.C.; Roellig, D.M.; Dunn, J.R.; Schaffner, W.; et al. Cryptosporidiosis outbreak associated with a single hotel. J. Environ. Health 2017, 79, 16–22. [Google Scholar] [PubMed]
  53. Huang, W.; Guo, Y.; Lysen, C.; Wang, Y.; Tang, K.; Seabolt, M.H.; Yang, F.; Cebelinski, E.; Gonzalez-Moreno, O.; Hou, T.; et al. Multiple introductions and recombination events underlie the emergence of a hyper-transmissible Cryptosporidium hominis subtype in the USA. Cell Host Microbe 2023, 31, 112–123.e4. [Google Scholar] [CrossRef] [PubMed]
  54. Wang, T.; Wei, Z.; Zhang, Y.; Zhang, Q.; Zhang, L.; Yu, F.; Qi, M.; Zhao, W. Molecular detection and genetic characterization of Cryptosporidium in kindergarten children in Southern Xinjiang, China. Infect. Genet. Evol. 2022, 103, 105339. [Google Scholar] [CrossRef] [PubMed]
  55. Robinson, G.; Chalmers, R.M.; Elwin, K.; Guy, R.A.; Bessonov, K.; Troell, K.; Xiao, L. Deciphering a cryptic minefield: A guide to Cryptosporidium gp60 subtyping. Curr. Res. Parasitol. Vector-Borne Dis. 2025, 7, 100257. [Google Scholar] [CrossRef] [PubMed]
  56. Ye, J.; Xiao, L.; Ma, J.; Guo, M.; Liu, L.; Feng, Y. Anthroponotic enteric parasites in monkeys in public park, China. Emerg. Infect. Dis. 2012, 18, 1640–1643. [Google Scholar] [CrossRef] [PubMed]
  57. Du, S.Z.; Zhao, G.H.; Shao, J.F.; Fang, Y.Q.; Tian, G.R.; Zhang, L.X.; Wang, R.J.; Wang, H.Y.; Qi, M.; Yu, S.K. Cryptosporidium spp., Giardia intestinalis, and Enterocytozoon bieneusi in captive non-human primates in Qinling Mountains. Korean J. Parasitol. 2015, 53, 395–402. [Google Scholar] [CrossRef] [PubMed]
  58. Qi, M.; Xi, J.; Li, J.; Wang, H.; Ning, C.; Zhang, L. Prevalence of zoonotic Giardia duodenalis assemblage B and first identification of assemblage E in rabbit fecal samples isolates from Central China. J. Eukaryot. Microbiol. 2015, 62, 810–814. [Google Scholar] [CrossRef] [PubMed]
  59. Feng, Y.; Xiao, L. Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clin. Microbiol. Rev. 2011, 24, 110–140. [Google Scholar] [CrossRef] [PubMed]
  60. Dan, J.; Zhang, X.; Ren, Z.; Wang, L.; Cao, S.; Shen, L.; Deng, J.; Zuo, Z.; Yu, S.; Wang, Y.; et al. Occurrence and multilocus genotyping of Giardia duodenalis from post-weaned dairy calves in Sichuan Province, China. PLoS ONE 2019, 14, e0224627. [Google Scholar] [CrossRef] [PubMed]
  61. Zahedi, A.; Field, D.; Ryan, U. Molecular typing of Giardia duodenalis in humans in Queensland–first report of assemblage E. Parasitology 2017, 144, 1154–1161. [Google Scholar] [CrossRef] [PubMed]
  62. Abdel-Moein, K.A.; Saeed, H. The Zoonotic potential of Giardia intestinalis assemblage E in rural settings. Parasitol. Res. 2016, 115, 3197–3202. [Google Scholar] [CrossRef] [PubMed]
  63. Fantinatti, M.; Bello, A.R.; Fernandes, O.; Da-Cruz, A.M. Identification of Giardia lamblia assemblage E in humans points to a new anthropozoonotic cycle. J. Infect. Dis. 2016, 214, 1256–1259. [Google Scholar] [CrossRef] [PubMed]
  64. Wang, Y.; Yu, F.; Zhang, K.; Shi, K.; Chen, Y.; Li, J.; Li, X.; Zhang, L. End-point RPA-CRISPR/Cas12a-based detection of Enterocytozoon bieneusi nucleic acid: Rapid, sensitive and specific. BMC Vet. Res. 2024, 20, 540. [Google Scholar] [CrossRef] [PubMed]
  65. Nemati, S.; Sadeghi, A.; Khoshfetrat, S.M.; Rahimi, H.M.; Omidfar, K.; Mirjalali, H. Development and synthesis of DNA-based label-free electrochemical biosensor for detection of Enterocytozoon bieneusi using screen-printed gold electrode. BMC Chem. 2025, 19, 184. [Google Scholar] [CrossRef] [PubMed]
  66. Liu, A.; Gong, B.; Liu, X.; Shen, Y.; Wu, Y.; Zhang, W.; Cao, J. A retrospective epidemiological analysis of human Cryptosporidium infection in China during the past three decades (1987–2018). PLoS Negl. Trop. Dis. 2020, 14, e0008146. [Google Scholar] [CrossRef] [PubMed]
  67. Jiang, S.; Li, H.; Zhang, L.; Mu, W.; Zhang, Y.; Chen, T.; Wu, J.; Tang, H.; Zheng, S.; Liu, Y.; et al. Generic Diagramming Platform (GDP): A comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025, 53, D1670–D1676. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Geographical distribution of patient origins and the location of Jinyintan Hospital. Among 150 patients, 140 were from 13 cities in Hubei Province, with 5 additional cases from three adjacent provincial cities (Xinyang, Henan Province; Jiujiang, Jiangxi Province; Chengdu, Sichuan Province). Geographical information was unavailable for five patients.
Figure 1. Geographical distribution of patient origins and the location of Jinyintan Hospital. Among 150 patients, 140 were from 13 cities in Hubei Province, with 5 additional cases from three adjacent provincial cities (Xinyang, Henan Province; Jiujiang, Jiangxi Province; Chengdu, Sichuan Province). Geographical information was unavailable for five patients.
Microorganisms 13 01731 g001
Figure 2. Oocysts of Cryptosporidium via indirect immunofluorescence assay. Oocysts of Cryptosporidium meleagridis (A), Cryptosporidium hominis (B), and Cryptosporidium parvum (C) displaying apple-green fluorescence (excitation 488 nm) via indirect immunofluorescence microscopy. Scale bar = 10 μm.
Figure 2. Oocysts of Cryptosporidium via indirect immunofluorescence assay. Oocysts of Cryptosporidium meleagridis (A), Cryptosporidium hominis (B), and Cryptosporidium parvum (C) displaying apple-green fluorescence (excitation 488 nm) via indirect immunofluorescence microscopy. Scale bar = 10 μm.
Microorganisms 13 01731 g002
Table 1. Demographic characteristics, and infections of Cryptosporidium spp. and Giardia duodenalis among enrolled AIDS patients 1.
Table 1. Demographic characteristics, and infections of Cryptosporidium spp. and Giardia duodenalis among enrolled AIDS patients 1.
GroupsNumber of CasesCryptosporidium spp.G. duodenalisCombined Mono-Infections
Positive [n (%)]p-ValuePositive [n (%)]p-ValuePositive [n (%)]p-Value
Age19–343600.59200.26800.070
35–49412 (4.88)3 (7.32)5 (12.20)
50–64571 (1.75)2 (3.51)3 (5.26)
65–8012000
GenderMale1352 (1.48)0.3445 (3.70)1.0006 (4.44)0.223
Female111 (9.09)01 (9.09)
Residential areaUrban5700.29400.14400.016
Rural893 (3.37)5 (5.62)8 (8.99)
Receiving ART therapyYes4900.2933 (6.12)0.6743 (6.12)0.697
No973 (3.09)2 (2.06)5 (5.15)
1. Only 146 patients provided complete demographic data.
Table 2. Sequence analysis of SSU rRNA and gp60 loci of Cryptosporidium spp.
Table 2. Sequence analysis of SSU rRNA and gp60 loci of Cryptosporidium spp.
Species (Accession No.)Subtype (Accession No.)Representative Sequences with 100% Identity in gp60 Analysis 1
HostAreaAccession No.
C. hominis (PV664588)IfA12G1R5 (PV672204)humanUKEU161655
Southern IrelandMT053131
NetherlandMH796380
AustraliaGU933448
C. parvum (PV664589)IIcA5G3 (PV672205)humanSouth Africa 2AF440621
Jamaica 2EU141721
Mozambique 2AF440631
C. meleagridis (PV664587)IIIbA22G1R1c (PV672203)humanIndiaKJ210607
ChinaKY575457
chickenChinaMG969391
1. Accession nos. of sequences with 100% identity are listed in Table S3; 2 Sequences were derived from fecal specimens of HIV-infected individuals.
Table 3. Sequence analysis of bg, tpi, and gdh loci of Giardia duodenalis-positive specimens.
Table 3. Sequence analysis of bg, tpi, and gdh loci of Giardia duodenalis-positive specimens.
Target GeneAssemblage (n)Specimen NumberAccession No.Sequences with 100% Identity 1
HostAccession No.
bgAssemblage B (3)No. 1PV683349humanOP947121
No. 2PV683351humanLC436571
No. 3PV683348humanKP687755
hylobatidaeKY696833
Assemblage E (1)No. 4PV683347sheepMN833266
calf/cattleKY769091 2
horseMN174850
tpiAssemblage A (1)No. 5PV700082humanOR453274
cattleOL694043
yakMH230890
sheepMN833280
Assemblage B (2)No. 1PV672206humanLN626348
No. 2PV672207
gdhAssemblage B (2)No. 1PV672208humanEF507682
No. 2PV672209hylobatidaeKY696799
rabbitKC960645
1 Accession nos. of sequences showing 100% identity in sequence analysis, with host and geographic location arelisted in Table S3. 2 Sequence was derived from fecal specimens of cattle in Chengdu, which is the residential area of the patient infected with G. duodenalis assemblage E.
Table 4. Statistical analysis of infection occurrence with immunity status, therapeutic status, and clinical manifestations1.
Table 4. Statistical analysis of infection occurrence with immunity status, therapeutic status, and clinical manifestations1.
Clinical ManifestationCategoriesNumber of CasesCryptosporidium spp.G. duodenalisCombined Mono-Infections
Positive [n (%)]p-ValuePositive [n (%)]p-ValuePositive [n (%)]p-Value
CD4+ T cell count<1001093 (2.75)0.5523 (2.75)0.6456 (5.50)0.433
101–2003702 (5.41)2 (5.41)
Diarrhea 2Yes273 (11.11)0.0051 (3.70)0.344 (14.81)0.046
No11904 (3.36)4 (3.36)
VomitingYes801.00001.00000.359
No1383 (2.17)5 (3.62)8 (5.80)
Decreased appetiteYes211 (4.76)0.47800.3261 (4.76)0.438
No1252 (1.60)5 (4.00)7 (5.60)
Abdominal painYes901.001 (11.1)0.3401 (11.1)0.435
No1373 (2.19)4 (2.92)7 (5.11)
FeverYes251 (4.00)0.51300.3191 (4.00)0.435
No1212 (1.65)5 (4.13)7 (5.79)
FatigueYes4300.2933 (6.98)0.0883 (6.98)0.418
No1033 (2.91)2 (1.94)5 (4.85)
1 Only 146 patients provided complete demographic data. 2 The patients were diagnosed as having diarrhea if their Bristol stool scale value was ≥ 6.
Table 5. Number and positivity rates of specimens collected in each season.
Table 5. Number and positivity rates of specimens collected in each season.
Season (Months)Number of SpecimensCryptosporidium spp.Giardia duodenalisTotal Number of Test-Positive
Positive [n (%)]p-ValuePositive [n (%)]p-ValuePositive [n (%)]p-Value
Winter (Dec–Feb)531 (1.89)0.3942(3.77)0.2213 (5.67)0.102
Spring (Mar–May)322 (6.25)3 (9.38)5 (15.63)
Summer (Jun–Aug)36000
Autumn (Sep–Nov)29000
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tao, Z.; Hong, K.; Qin, P.; Liu, H.; Wang, C.; Yin, J.; Li, X.; Zhu, G.; Hu, M. Emergence of Cryptosporidium parvum IIc Subtype and Giardia duodenalis Assemblage E in AIDS Patients in Central China: Evidence for Neglected Transmission Dynamics. Microorganisms 2025, 13, 1731. https://doi.org/10.3390/microorganisms13081731

AMA Style

Tao Z, Hong K, Qin P, Liu H, Wang C, Yin J, Li X, Zhu G, Hu M. Emergence of Cryptosporidium parvum IIc Subtype and Giardia duodenalis Assemblage E in AIDS Patients in Central China: Evidence for Neglected Transmission Dynamics. Microorganisms. 2025; 13(8):1731. https://doi.org/10.3390/microorganisms13081731

Chicago/Turabian Style

Tao, Zhuolin, Ke Hong, Peixi Qin, Hui Liu, Chunqun Wang, Jigang Yin, Xin Li, Guan Zhu, and Min Hu. 2025. "Emergence of Cryptosporidium parvum IIc Subtype and Giardia duodenalis Assemblage E in AIDS Patients in Central China: Evidence for Neglected Transmission Dynamics" Microorganisms 13, no. 8: 1731. https://doi.org/10.3390/microorganisms13081731

APA Style

Tao, Z., Hong, K., Qin, P., Liu, H., Wang, C., Yin, J., Li, X., Zhu, G., & Hu, M. (2025). Emergence of Cryptosporidium parvum IIc Subtype and Giardia duodenalis Assemblage E in AIDS Patients in Central China: Evidence for Neglected Transmission Dynamics. Microorganisms, 13(8), 1731. https://doi.org/10.3390/microorganisms13081731

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop